Increased Mortality Associated With Low Use of Clopidogrel in Patients With Heart Failure and Acute Myocardial Infarction Not Undergoing Percutaneous Coronary Intervention. A Nationwide Study

Journal of the American College of Cardiology

Volumn 55, Issue 13, 2010, Pages 1300-1307

  Bonde, Lisbeth ^a   Sorensen, Rikke ^a   Fosbøl, Emil Loldrup ^a   Abildstrøm, Steen Zabell ^b,c   Hansen, Peter Riis ^a   Kober, Lars ^d   Schramm, Tina Ken ^a   Bretler, Ditte Marie ^a   Weeke, Peter ^a   Olesen, Jonas ^a   Torp Pedersen, Christian ^a   Gislason, Gunnar Hilmar ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

acute myocardial infarction; clopidogrel; heart failure; mortality; pharmacoepidemiology

Indexed keywords

ANTIDIABETIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; KAPLAN MEIER METHOD; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DENMARK; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TICLOPIDINE;

EID: 77949543994     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.11.057     Document Type: Article

References (28)

1. Lip G.Y., and Gibbs C.R. Does heart failure confer a hypercoagulable state?. Virchow's triad revisited. J Am Coll Cardiol 33 (1999) 1424-1426
2. Steg P.G., Dabbous O.H., Feldman L.J., et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004) 494-499
3. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28 (2007) 1598-1660
4. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction. J Am Coll Cardiol 50 (2007) e1-e157
5. Antman E.M., Hand M., Armstrong P.W., et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. J Am Coll Cardiol 51 (2008) 210-247
6. The CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
7. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
8. Chen Z.M., Jiang L.X., Chen Y.P., et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
9. Durand-Zaleski I., and Bertrand M. The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study. Pharmacoeconomics 22 Suppl 4 (2004) 19-27
10. Tricoci P., Roe M.T., Mulgund J., et al. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med 166 (2006) 806-811
11. Krum H., Meehan A., Varigos J., Loane P.R., and Billah B. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?. A multicentre study. Med J Aust 185 (2006) 191-194
12. Sørensen R., Gislason G.H., Fosbol E.L., et al. Initiation and persistence with clopidogrel treatment after acute myocardial infarction-a nationwide study. Br J Clin Pharmacol 66 (2008) 875-884
13. Alexander D., Ou F.S., Roe M.T., et al. Use of in-hospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). Am Heart J 156 (2008) 606-612
14. Malinin A.I., O'Connor C.M., Dzhanashvili A.I., Sane D.C., and Serebruany V.L. Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?. Am Heart J 145 (2003) 397-403
15. Serebruany V.L., Malinin A.I., Jerome S.D., et al. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial. Am Heart J 146 (2003) 713-720
16. Gaist D., Sorensen H.T., and Hallas J. The Danish prescription registries. Dan Med Bull 44 (1997) 445-448
17. Tu J.V., Austin P.C., Walld R., Roos L., Agras J., and McDonald K.M. Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol 37 (2001) 992-997
18. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., et al. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation 116 (2007) 737-744
19. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27 (2006) 1153-1158
20. Gmatch macro for SAS, Mayo Clinic College of Medicine. http://ndc.mayo.edu/mayo/research/biostat/upload/gmatch.sas Accessed May 1, 2008
21. Yusuf S., Mehta S.R., Zhao F., et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 107 (2003) 966-972
22. Penning-van Beest F.J., van Meegen E., Rosendaal F.R., and Stricker B.H. Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation. Thromb Haemost 86 (2001) 569-574
23. Massie B.M., Collins J.F., Ammon S.E., et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial. Circulation 119 (2009) 1616-1624
24. Pullicino P., Thompson J.L., Barton B., Levin B., Graham S., and Freudenberger R.S. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. J Card Fail 12 (2006) 39-46
25. Meune C., Wahbi K., Fulla Y., et al. Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors. Eur J Heart Fail 9 (2007) 197-201
26. Madsen M., Davidsen M., Rasmussen S., Abildstrom S.Z., and Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56 (2003) 124-130
27. Kumler T., Gislason G.H., Kirk V., et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 10 (2008) 658-660
28. D'Agostino Jr. R.B. Propensity scores in cardiovascular research. Circulation 115 (2007) 2340-2343